|
1
|
Chabanol H, Huillard O, Prin L, Villeminey C, Rondeau A, Boudou-Rouquette P, Astorg F, Musenghesi B, Du Mortier C, Alexandre J, Goldwasser F. [Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results]. Bull Cancer 2018; 105:1173-1182. [PMID: 30078546 DOI: 10.1016/j.bulcan.2018.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2018] [Revised: 05/16/2018] [Accepted: 06/18/2018] [Indexed: 10/28/2022]
Abstract
BACKGROUND Docetaxel is frequently used for the treatment of metastatic prostate cancer patients. Nail toxicity is a commonly described side effect, but no precise recommendation exists concerning its management. We experimented the integration of a podiatrist in routine cancer care. METHODS Patients having received docetaxel for a metastatic prostate cancer since the arrival of the podiatrist were studied. RESULTS Fifty-six patients were included, half had docetaxel-induced nail toxicity and 18 were referred to the podiatrist. The integration of the podiatrist in routine care was feasible and allowed characterizing nail toxicity. The main lesions observed were non-coagulated nail hematomas, coagulated nail hematomas and onycholysis. This experience led to propose an integrated care for docetaxel-induced nail toxicity. CONCLUSION The integration of podiatrist care is feasible in routine cancer care and can help improving the management of docetaxel-induced nail toxicity in metastatic prostate cancer patients.
Collapse
Affiliation(s)
- Hedi Chabanol
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| | - Olivier Huillard
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France.
| | - Lucie Prin
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| | - Clémentine Villeminey
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| | - Aurélie Rondeau
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| | - Pascaline Boudou-Rouquette
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| | - Florence Astorg
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| | - Beatrice Musenghesi
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| | - Catherine Du Mortier
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| | - Jerome Alexandre
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| | - Francois Goldwasser
- AP-HP, hôpital Cochin Port-Royal, service de cancérologie, 123, boulevard Port-Royal, 75014 Paris, France
| |
Collapse
|